Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD

Shahid Beheshti University of Medical Sciences

Overview

To compare the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal bevacizumab versus combination of photodynamic therapy , intravitreal bevacizumab and intravitreal triamcinolone for neovascular AMD.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Conditions

Neovascular Age-Related Macular Degeneration

Interventions

verteporfin, bevacizumab, triamcinolone acetonideDRUG

Eligibility

Sex: ALLMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Cases of active neovascular AMD with visual acuity of 20/400- 20/40 Exclusion Criteria: * History of glaucoma or ocular hypertension * Disciform scar

Locations (1)

Hamid Ahmadieh, MD

Tehran, Tehran Province, Iran

RECRUITING

Outcomes

Primary Outcomes

Visual acuity

Secondary Outcomes

Central macular thickness

Leakage in fluorescein angiography

Intraocular pressure

Anterior chamber reaction

Central Contacts

Hamid Ahmadieh, MD

CONTACT

+98 21 22585952 hahmadieh@hotmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.